Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

16.7%

1 terminated/withdrawn out of 6 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

100%

3 of 3 completed trials have results

Key Signals

3 with results

Enrollment Performance

Analytics

N/A

3(60.0%)

Phase 4

1(20.0%)

Phase 2

1(20.0%)

5Total

N/A(3)

Phase 4(1)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT01819467Not ApplicableTerminated

A Trial to Reduce Adhesions Following a Primary Cesarean Section

Role: collaborator

NCT01825187Not ApplicableCompleted

Prospective Trial Comparing Two Different Polypropylene Meshes for Inguinal Hernias

Role: collaborator

NCT03545503Phase 4Completed

Evaluating the Hemodynamic Effects of Ketamine Versus Etomidate During Rapid Sequence Intubation

Role: collaborator

NCT01372111Phase 2Unknown

Chemoradiotherapy With Elective Low Dose Nodal Radiation for Locally Advanced Head and Neck Cancer

Role: collaborator

NCT01400399Unknown

Cosmetic Evaluation of Lumpectomy Versus Oncolytic Mammoplasty With Bilateral Breast Reduction for Early Stage Breast Cancer

Role: collaborator

NCT01622647Not ApplicableCompleted

The Effect of Nasal Continuous Positive Airway Pressure (N-CPAP) on Arterial pCO2 During Spinal Anesthesia

Role: collaborator

All 6 trials loaded